Published in J Immunol on November 15, 1994
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med (2003) 6.73
High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J Exp Med (2000) 2.10
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med (2013) 1.88
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A (2006) 1.79
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response. PLoS One (2013) 1.57
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest (1995) 1.54
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med (2009) 1.34
A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc Natl Acad Sci U S A (1997) 1.33
MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33
Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med (1999) 1.33
Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med (2005) 1.30
CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J Neuroinflammation (2005) 1.27
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 1.24
Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol (2007) 1.16
The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease. J Neurol (1996) 1.15
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflammation (2007) 1.15
A resource for the simultaneous high-resolution mapping of multiple quantitative trait loci in rats: the NIH heterogeneous stock. Genome Res (2008) 1.13
Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc Natl Acad Sci U S A (2002) 1.11
Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods Mol Biol (2012) 1.11
Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol (2001) 1.07
Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. J Clin Invest (2004) 1.03
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE. Neurol Neuroimmunol Neuroinflamm (2014) 1.01
Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathol (2015) 1.00
C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol (1999) 0.99
Studies in the modulation of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 0.95
Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats. PLoS One (2012) 0.95
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity (2008) 0.92
Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol (2006) 0.91
Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis. Exp Brain Res (2004) 0.90
Target specificity of an autoreactive pathogenic human γδ-T cell receptor in myositis. J Biol Chem (2012) 0.88
Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays. PLoS One (2009) 0.88
A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice. J Immunol (2012) 0.88
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol (2000) 0.88
Experimental Autoimmune Encephalomyelitis in Mice. Methods Mol Biol (2016) 0.86
Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Arch Neurol (2010) 0.86
B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells. J Autoimmun (2010) 0.84
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice. Glia (2014) 0.83
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis. J Biol Chem (2015) 0.82
Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat. PLoS One (2010) 0.82
Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats. J Immunol (2013) 0.82
Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis. Immunology (2002) 0.81
Genetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injury. J Neuroinflammation (2013) 0.81
Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. PLoS One (2013) 0.81
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunology (2013) 0.81
Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase for BALB/c and SJL mice. Immunology (1998) 0.80
Parent-of-origin effects implicate epigenetic regulation of experimental autoimmune encephalomyelitis and identify imprinted Dlk1 as a novel risk gene. PLoS Genet (2014) 0.80
Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 0.80
Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice. Genetics (2006) 0.80
Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.79
Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells. PLoS One (2012) 0.79
'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides. PLoS One (2011) 0.78
Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity. J Biol Chem (2012) 0.78
Cross-reactive myelin antibody induces renal pathology. Autoimmunity (2008) 0.77
Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity. Hum Mol Genet (2013) 0.77
High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.77
Extensive RNA editing and splicing increase immune self-representation diversity in medullary thymic epithelial cells. Genome Biol (2016) 0.76
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis. Front Immunol (2016) 0.75
Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. Front Neurosci (2016) 0.75
Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis . Proc Natl Acad Sci U S A (2017) 0.75
Role of B:T cell ratio in suppression of clinical signs: a model for silent MS. Exp Mol Pathol (2008) 0.75
Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases. Immunology (2016) 0.75
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. Front Immunol (2017) 0.75
Neurofilament Light as an Immune Target for Pathogenic Antibodies. Immunology (2017) 0.75
The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med (1997) 12.21
Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions. J Mol Biol (1997) 10.38
Contact order, transition state placement and the refolding rates of single domain proteins. J Mol Biol (1998) 8.51
Native protein sequences are close to optimal for their structures. Proc Natl Acad Sci U S A (2000) 7.99
Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men. Am J Public Health (1981) 6.91
Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol (1996) 6.51
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Consistent land- and atmosphere-based U.S. carbon sink estimates. Science (2001) 5.49
Recent patterns and mechanisms of carbon exchange by terrestrial ecosystems. Nature (2001) 5.11
Improved recognition of native-like protein structures using a combination of sequence-dependent and sequence-independent features of proteins. Proteins (1999) 4.86
Job strain and cardiovascular disease. Annu Rev Public Health (1994) 4.59
Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins (1999) 3.79
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob Agents Chemother (2000) 3.54
Experiment and theory highlight role of native state topology in SH3 folding. Nat Struct Biol (1999) 3.50
Research priorities. Shining light into black boxes. Science (2012) 3.06
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol (2001) 3.05
Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain. Nat Struct Biol (1998) 3.02
The natural history of spondylolysis and spondylolisthesis. J Bone Joint Surg Am (1984) 3.02
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97
Clustering of low-energy conformations near the native structures of small proteins. Proc Natl Acad Sci U S A (1998) 2.92
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA (2000) 2.91
Protein transport to the vacuole and receptor-mediated endocytosis by clathrin heavy chain-deficient yeast. J Cell Biol (1988) 2.86
Prediction of protein-folding mechanisms from free-energy landscapes derived from native structures. Proc Natl Acad Sci U S A (1999) 2.86
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis (2009) 2.68
Development of the AHCPR-sponsored heart failure guideline: methodologic and procedural issues. Jt Comm J Qual Improv (1994) 2.61
Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr (1999) 2.59
Prediction of local structure in proteins using a library of sequence-structure motifs. J Mol Biol (1998) 2.50
Critical role of beta-hairpin formation in protein G folding. Nat Struct Biol (2000) 2.46
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis (2008) 2.45
Prospects for ab initio protein structural genomics. J Mol Biol (2001) 2.43
Topology, stability, sequence, and length: defining the determinants of two-state protein folding kinetics. Biochemistry (2000) 2.42
De novo protein structure determination using sparse NMR data. J Biomol NMR (2000) 2.37
Role of neurogenic genes in establishment of follicle cell fate and oocyte polarity during oogenesis in Drosophila. Cell (1991) 2.33
Successful techniques for retention of study participants in an inner-city population. Control Clin Trials (1998) 2.32
Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol (1998) 2.31
Late complications of immune deviation therapy in a nonhuman primate. Science (1996) 2.30
HMMSTR: a hidden Markov model for local sequence-structure correlations in proteins. J Mol Biol (2000) 2.26
A breakdown of symmetry in the folding transition state of protein L. J Mol Biol (2000) 2.26
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol (1998) 2.22
Computer-based redesign of a protein folding pathway. Nat Struct Biol (2001) 2.17
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab (1999) 2.13
Toward high-resolution prediction and design of transmembrane helical protein structures. Proc Natl Acad Sci U S A (2007) 2.12
Functional rapidly folding proteins from simplified amino acid sequences. Nat Struct Biol (1997) 2.08
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience (2006) 2.07
Rosetta in CASP4: progress in ab initio protein structure prediction. Proteins (2001) 2.07
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
Ab initio protein structure prediction: progress and prospects. Annu Rev Biophys Biomol Struct (2001) 2.05
Measuring empathy: reliability and validity of the Empathy Quotient. Psychol Med (2004) 1.99
Design and methods of the National Cooperative Inner-City Asthma Study. Pediatr Pulmonol (1997) 1.95
A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol (1987) 1.92
Chain collapse can occur concomitantly with the rate-limiting step in protein folding. Nat Struct Biol (1999) 1.92
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia (2001) 1.91
Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod (2008) 1.89
Animal models. Ann Neurol (1994) 1.88
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Kinetics of folding of the IgG binding domain of peptostreptococcal protein L. Biochemistry (1997) 1.83
Mechanisms of protein folding. Curr Opin Struct Biol (2001) 1.80
Matching theory and experiment in protein folding. Curr Opin Struct Biol (1999) 1.79
Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability. Proc Natl Acad Sci U S A (1997) 1.78
Limited internal friction in the rate-limiting step of a two-state protein folding reaction. Proc Natl Acad Sci U S A (1998) 1.74
Prediction of membrane protein structures with complex topologies using limited constraints. Proc Natl Acad Sci U S A (2009) 1.73
Folding dynamics of the src SH3 domain. Biochemistry (1997) 1.72
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol (1995) 1.71
Molecular dynamics in the endgame of protein structure prediction. J Mol Biol (2001) 1.69
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol (1991) 1.65
The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol (1993) 1.59
Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol (1999) 1.57
Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann Neurol (1992) 1.57
NMR characterization of residual structure in the denatured state of protein L. J Mol Biol (2000) 1.57
Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax (1984) 1.55
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest (1995) 1.54
Improving the performance of Rosetta using multiple sequence alignment information and global measures of hydrophobic core formation. Proteins (2001) 1.54
Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem (1989) 1.53
A desolvation barrier to hydrophobic cluster formation may contribute to the rate-limiting step in protein folding. Protein Sci (1997) 1.52
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature (1989) 1.49
Oral health literacy among female caregivers: impact on oral health outcomes in early childhood. J Dent Res (2010) 1.49
Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest (1997) 1.47
Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol (2010) 1.47
Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis. J Rheumatol (1990) 1.46
The sequences of small proteins are not extensively optimized for rapid folding by natural selection. Proc Natl Acad Sci U S A (1998) 1.45
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis (2007) 1.44
Simplified proteins: minimalist solutions to the 'protein folding problem'. Curr Opin Struct Biol (1998) 1.43
The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci (1994) 1.43
Contextual variations in the meaning of health inequality. Soc Sci Med (1991) 1.42
Myelination in rat brain aggregating cell cultures. Neuroscience (1978) 1.42
An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse. Br J Ophthalmol (2001) 1.42
Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (1988) 1.41
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain (1998) 1.41
Experimental encephalomyelitis modulates inositol and taurine in the spinal cord of Biozzi mice. Magn Reson Med (1994) 1.40
Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax (1989) 1.40
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J (2006) 1.40
The anatomy of an OPTI: Part 2. The CORE system. Ohio Osteopathic Hospital Association. Ohio Association of Osteopathic Medical Directors. Ohio Osteopathic Association. J Am Osteopath Assoc (1997) 1.39
A phage display system for studying the sequence determinants of protein folding. Protein Sci (1995) 1.36